India Steps Up MedTech Export Push as Domestic Manufacturing Gains Speed

To further support industry growth and future MedTech export expansion, the government has been developing medical device parks that offer shared, world-class infrastructure.

India has ramped up efforts to scale up MedTech export capacity and domestic manufacturing, with exports of medical devices growing from $2.9 billion to $4.1 billion.

It has outlined strategies covering regulatory streamlining, enabling infrastructure, research and innovation, investment facilitation, workforce development, and global positioning.

These have been supported through multiple Central Sector schemes led by the Department of Pharmaceuticals, which has been coordinating closely with industry, academia and other ministries.

The Scheme for Strengthening the Medical Device Industry, begun in November 2024 with an outlay of ₹500 crore, has placed emphasis on capability building in component manufacturing, skills, clinical studies, common facilities, and industry promotion.

It contains sub-schemes related to reducing import dependence, supporting clusters with unique capabilities, and facilitating clinical validation.

A dedicated portal has also been developed to track the progress of these actions across the departments and the national regulator.

Consequently, the country's MedTech export performance has strengthened significantly, with outbound shipments rising from USD 2.9 billion in FY2021-22 to USD 4.1 billion in FY2024-25.

The government said this was an indication of the industry's competitiveness, which has gained steadily alongside rapid growth in domestic manufacturing.

A key catalyst for such progress has been the Production Linked Incentive (PLI) Scheme for medical devices, carrying an outlay of ₹3,420 crore and running from FY2022-23 to FY2026-27. The incentive supports incremental sales of made-in-India products across radiotherapy, imaging, anaesthesia, critical care and implant categories.

At the end of September 2025, 22 greenfield projects had been commissioned, and 55 products were already being manufactured, including several high-end devices for which India has historically depended on imports, such as linear accelerators, MRI and CT scan systems, mammography machines, C-arm X-ray units, MRI coils and ultrasound equipment.

Eligible sales under the scheme have reached ₹12,344.37 crore, with exports accounting for ₹5,869.36 crore.

To further support industry growth and future MedTech export expansion, the government has been developing medical device parks that offer shared, world-class infrastructure.

Such parks in Greater Noida, Ujjain, and Kanchipuram, collectively having a project cost of ₹ 871.11 crore, are nearing completion.

Central assistance of ₹ 100 crore per park was granted under the scheme, and as of September 2025, land had been allotted to 194 manufacturers, out of which 34 units had already begun plant construction.

The Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel emphasized that these collective interventions have positioned the sector for higher growth in MedTech exports over the coming years.

Stay tuned for more such updates on Digital Health News